Home›Companies›Healthcare›SynerFuse

SynerFuse, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 15, 2023·Suggest an edit

About SynerFuse

SynerFuse is a private company based in Eden Prairie, Minnesota. It has reported $6,513,765 raised in four offerings on Form D since May 2019. Its chief executive is Justin Zenanko.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetFeb 15, 2023$0of $25.0M target0—EquityRule 506(b), 4a5Form D ↗
Jun 30, 2021Jul 15, 2021$275,000of $30.0M target3$91,667EquityRule 504, Rule 506(b), 4a5Form D ↗
Dec 23, 2019Apr 20, 2021$3,596,940of $3.6M target54$66,610EquityRule 504, 04.2, 4a5Form D ↗
Sep 9, 2018May 17, 2019$2,641,825fully sold54$48,923EquityRule 504, Rule 506(b), 4a5Form D ↗
Total, four offerings$6,513,765

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SynerFuse's Form D filed Feb 15, 2023.

EP
GM
Gregory Molnar
Executive officer and director
JZ
Justin Zenanko
President and CEO, director
EN
DM
Dennis McFadden
Executive officer

Earlier filings also listed Susan Alpert (executive officer, last listed Jul 2021), Nazmi Peyman (director, last listed Jul 2021), Jeff Fritz (director, last listed Jul 2021), Brian Highley (director, last listed Jul 2021), Timothy Skaja (director, last listed May 2019), Theresa Pesch Hilgers (director, last listed May 2019), Omid Souresrafil (promoter, last listed May 2019) and Jeff O'Dell (director, last listed May 2019).

Sources

  1. SECSynerFuse, Inc. filing history